Surgical treatment of Asherman syndrome and reproductive outcome

被引:0
|
作者
Hansen, Bent Brandt [1 ]
Nohr, Bugge [2 ]
机构
[1] Copenhagen Univ Hosp, Herlev Hosp, Dept Obstet & Gynaecol, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Herlev Hosp, Dept Obstet & Gynaecol, Fertil Clin, Copenhagen, Denmark
来源
DANISH MEDICAL JOURNAL | 2022年 / 69卷 / 03期
关键词
INTRAUTERINE; MANAGEMENT; PLACENTA;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Asherman syndrome may be challenging to treat. This study presented the results after hysteroscopic treatment of Asherman syndrome in our clinic focusing on the reproductive outcome. Methods. A total of 43 women were operated in the course of a five-year period. The women were post-operatively treated with hyaluronic acid gel, intrauterine device (IUD) and hormonal supplementation. A second-look minihysteroscopy and removal of the IUD were conducted seven weeks later. Data concerning the results after one or more operations were obtained from a phone interview and from the medical records. Results. The pregnancy rate among the 38 women who wished to conceive was 82%, and the live birth rate was 63%. Among the 31 women who became pregnant, 42% achieved spontaneous pregnancy, whereas 58% became pregnant after fertility treatments. An increased risk of obstetric complications was recorded, especially related to abnormal placentation and impaired placenta function. Conclusions. Hysteroscopic treatment of Asherman syndrome seems to be a safe procedure, but a risk possibly exists of obstetrical complications in the subsequent pregnancies. Pregnancies following hysteroscopic adhesiolysis should be considered high-risk pregnancies.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Management of Asherman's syndrome
    March, Charles M.
    REPRODUCTIVE BIOMEDICINE ONLINE, 2011, 23 (01) : 63 - 76
  • [42] CESAREAN-INDUCED ISTHMOCELE. SURGICAL HYSTEROSCOPIC TREATMENT AND REPRODUCTIVE OUTCOME
    Lotti, B.
    Raso, D.
    Insua, M. E.
    Fernandez, N.
    Cogorno, M.
    Neuspiller, E.
    FERTILITY AND STERILITY, 2013, 100 (03) : S397 - S397
  • [43] Severe Asherman's Syndrome
    Kabli, Nadia
    Tulandi, Togas
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2007, 29 (10) : 779 - 779
  • [44] The value of two stage laser treatment for severe Asherman's syndrome
    Chapman, R
    Chapman, K
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1996, 103 (12): : 1256 - 1258
  • [45] Transvaginal ovarian drilling: a new surgical treatment for improving the clinical outcome of assisted reproductive technologies in patients with polycystic ovary syndrome
    Ferraretti, AP
    Gianaroli, L
    Magli, MC
    Iammarrone, E
    Feliciani, E
    Fortini, D
    FERTILITY AND STERILITY, 2001, 76 (04) : 812 - 816
  • [46] Treatment of Asherman Syndrome with Adipose Derived Mesenchymal Stem Cells.
    Zolbin, Masoumeh Majidi
    Mamillapalli, Ramanaiah
    Ersoy, Gulcin Sahin
    Taylor, Hugh S.
    REPRODUCTIVE SCIENCES, 2019, 26 : 295A - 295A
  • [47] Fertility after treatment of Asherman's syndrome stage 3 and 4
    Fernandez, Herve
    Al-Najjar, Fadheela
    Chauveaud-Lambling, Aurelia
    Frydman, Rene
    Gervaise, Amelie
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2006, 13 (05) : 398 - 402
  • [48] A comprehensive review of Asherman's syndrome: causes, symptoms and treatment options
    Salazar, Christina A.
    Isaacson, Keith
    Morris, Stephanie
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2017, 29 (04) : 249 - 256
  • [49] Long-term reproductive outcome subsequent to medical versus surgical treatment for miscarriage
    Tam, WH
    Tsui, MHY
    Lok, IH
    Yip, SK
    Yuen, PM
    Chung, TKH
    HUMAN REPRODUCTION, 2005, 20 (12) : 3355 - 3359
  • [50] Outcome of Surgical Treatment in Late-Onset Capsular Block Syndrome
    Huang, Yang
    Ye, Zi
    Li, Hang
    Li, Zhaohui
    JOURNAL OF OPHTHALMOLOGY, 2017, 2017